- Home
- NERV vs BNRG Comparison
NERV vs BNRG Comparison
Compare NERV & BNRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- BNRG
- Stock Information
- Founded
- NERV 2007
- BNRG 2012
- Country
- NERV United States
- BNRG Israel
- Employees
- NERV N/A
- BNRG N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- BNRG
- Sector
- NERV Health Care
- BNRG
- Exchange
- NERV Nasdaq
- BNRG Nasdaq
- Market Cap
- NERV 12.4M
- BNRG 10.0M
- IPO Year
- NERV 2014
- BNRG 2022
- Fundamental
- Price
- NERV $1.59
- BNRG $1.06
- Analyst Decision
- NERV Hold
- BNRG
- Analyst Count
- NERV 1
- BNRG 0
- Target Price
- NERV $5.00
- BNRG N/A
- AVG Volume (30 Days)
- NERV 7.7K
- BNRG 67.7K
- Earning Date
- NERV 05-20-2025
- BNRG 03-04-2025
- Dividend Yield
- NERV N/A
- BNRG N/A
- EPS Growth
- NERV N/A
- BNRG N/A
- EPS
- NERV 0.19
- BNRG N/A
- Revenue
- NERV N/A
- BNRG N/A
- Revenue This Year
- NERV N/A
- BNRG N/A
- Revenue Next Year
- NERV N/A
- BNRG N/A
- P/E Ratio
- NERV $8.42
- BNRG N/A
- Revenue Growth
- NERV N/A
- BNRG N/A
- 52 Week Low
- NERV $1.15
- BNRG $0.60
- 52 Week High
- NERV $3.69
- BNRG $3.27
- Technical
- Relative Strength Index (RSI)
- NERV 46.58
- BNRG 41.17
- Support Level
- NERV $1.65
- BNRG $0.94
- Resistance Level
- NERV $1.75
- BNRG $1.42
- Average True Range (ATR)
- NERV 0.08
- BNRG 0.08
- MACD
- NERV -0.00
- BNRG -0.02
- Stochastic Oscillator
- NERV 31.03
- BNRG 28.20
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About BNRG Brenmiller Energy Ltd
Brenmiller Energy Ltd is a technology company that develops, produces, markets, and sells thermal energy storage. The technology of the company allows electrification and decarbonization of the industrial industry sector for integration with renewable energy sources and further reduction of carbon emissions.